Latest News about FDA
Recent news which mentions FDA
After Lung Cancer Approval, AstraZeneca's Imfinzi Goes Under FDA Priority Review For Bladder Cancer
December 06, 2024
From Benzinga
Merus Scores Its First FDA Approval For Lung Cancer Drug
December 05, 2024
From Benzinga
FDA Approves AstraZeneca's Blockbuster Cancer Drug Imfinzi For Aggressive Form Of Lung Cancer
December 05, 2024
From Benzinga
Supreme Court Hears Case Against FDA Ban On Flavored Vapes: Here Are The Stocks To Watch
December 02, 2024
From Benzinga
FDA Probes Potential Life-Threatening Blood Cancer Risks Linked To Bluebird Bio's Skysona Gene Therapy
November 29, 2024
From Benzinga
Regulatory Setback For Applied Therapeutics' Lead Program, FDA Highlights Deficiencies In Clinical Application
November 29, 2024
From Benzinga
Pharma-Grade Cannabis Could Hit Walgreens & CVS—But Can The Industry Survive The FDA?
November 28, 2024
From Benzinga
FDA Approves BridgeBio Pharma's Drug For Rare Heart Disease, Poised To Challenge Pfizer In Lucrative Yet Competitive Market
November 25, 2024
From Benzinga
Kennedy's War On Food Dyes Could Be Coming To Your Breakfast Table
November 22, 2024
From Benzinga
From Benzinga
FDA Greenlights Jazz Pharma's Cancer Drug, A Milestone For Zymework
November 21, 2024
From Benzinga
FDA Approves Cannabis Trial For Veterans With PTSD After Years Of Delays
November 20, 2024
Tickers
NEWS
From Benzinga
FDA Approves UCB's Psoriasis Drug For Expanded Use In Painful Inflammatory Skin Disease
November 20, 2024
From Benzinga
From Benzinga
FDA To Revisit Regeneron/Sanofi's Dupixent For Rare Skin Disease
November 15, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.